Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA approves updated label for Regeneron’s EYLEA treating wet AMD In a significant development for ophthalmic care, Regeneron Pharmaceuticals has received approval from the U.S. Food and Drug… bypharmanewsdailyAugust 19, 2018